AI brief of an SEC Form 8-K · Talon Capital Corp. (TLNC)

Talon Capital appoints Victoria Ivashina as independent director, audit committee member

Neutral Impact 2 of 5 leadership Written later

Talon Capital Corp., a special purpose acquisition company, appointed Dr. Victoria Ivashina as an independent director effective September 11, 2026, and to its audit committee. She is a Harvard Business School finance professor and a trustee of two Carlyle AlpInvest private markets funds. The filing reports no financial results, and the change is an administrative board addition.

Key points

  • Board appointed Dr. Victoria Ivashina as independent director effective September 11, 2026, and to the audit committee on the same date.
  • Dr. Ivashina is the Lovett-Learned Professor of Finance at Harvard Business School, and has served as a trustee of two Carlyle AlpInvest private markets funds since 2022.
  • Sponsor Talon Capital Sponsor LLC transferred 20,000 Class B ordinary shares to Dr. Ivashina under a September 11, 2026 agreement at approximately $0.003 per share.

The filing

CompanyTalon Capital Corp. (TLNC)
Form8-K, current report
Filed with the SECSep 15, 2026, 5:10 PM ET
Accession number0001213900-26-100199

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.